Anti-inflammatories may treat blindness
‘Canadian researchers have found that rheumatoid arthritis patients treated with anti-inflammatory drugs are 10 times less likely to develop age-related macular degeneration, the most common form of blindness in people over 55.
The study, recently published in the Neurobiology of Aging, is a joint effort between scientists at the University of British Columbia and University of Saskatchewan.
The scientists reviewed 993 rheumatoid arthritis patients in Saskatchewan aged 65 years or older who, on average, had been living with rheumatoid arthritis since age 51. Only three had developed age-related macular degeneration (AMD), whereas about 30 cases could be expected in a similarly-aged group from the general populace. ‘
Read more at Anti-inflammatories may treat blindness, Canadian researchers show
Recent Entries
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax